Genmab Updates 2023 Financial Guidance
Company Announcement COPENHAGEN, Denmark; July 28, 2023 – Genmab A/S (Nasdaq: GMAB) announced today its…
Month: July 2023
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in…
SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
Exercise of Procurement Options of Approximately $113 Million for Oral TPOXX and Approximately $25 Million…
Correction: Inventiva Reports Preliminary 2023 First-Half Financial Information¹ and Business update
Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million2, and long-term deposit…
PennyMac Mortgage Investment Trust Reports Second Quarter 2023 Results
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–PennyMac Mortgage Investment Trust (NYSE: PMT) today reported net income attributable to…
Inozyme Pharma, Inc. Announces Proposed Offering of Common Stock
BOSTON, July 27, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director
Appointment adds Dr. Powchik’s experience in the development of marketed immunotherapeutics to Vaxxinity’s leadership team…
Cellectis to Report Second Quarter 2023 Financial Results on August 3, 2023
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (the “Company”) (Euronext Growth: ALCLS-…
Myriad Genetics to Release Second Quarter Financial Results on Aug. 3, 2023
SALT LAKE CITY, July 27, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
PHAXIAM Therapeutics announces a reverse share split of its shares
PRESS RELEASE PHAXIAM Therapeutics announces a reverse share split of its shares Reverse share split…
Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
SOUTH SAN FRANCISCO, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS,…
Plus Therapeutics Strengthens Clinical Program with the Appointment of Pius Maliakal as Vice President of Clinical Operations
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU
Announced Today Encouraging Initial Clinical Data from First Dose Level of pheEDIT Trial Evaluating HMI-103 BEDFORD,…
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading…
Solarvest Receives Approval for Its Unique Algal Juice Media Patent
Vancouver, British Columbia–(Newsfile Corp. – July 27, 2023) – The Company (TSXV: SVS) is very…
Coursera Reports Second Quarter 2023 Financial Results
2023 revenue outlook midpoint raised by $15 million to $620 million 2023 Adjusted EBITDA margin…
Walgreens Boots Alliance Announces CFO Transition
James Kehoe to depart as Global CFO; Manmohan Mahajan appointed Interim Global CFO DEERFIELD, Ill.–(BUSINESS…
Fortune Brands Delivers Solid Sales and Strong Margin Results Amid Dynamic Macro Environment; Increases Full-Year 2023 Guidance
Highlights: Q2 2023 sales were $1.2 billion, a decrease of 7 percent versus Q2 2022…
Verisign Reports Second Quarter 2023 Results
RESTON, Va.–(BUSINESS WIRE)–VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and…
Cathay Pacific Selects Affirm as its Exclusive Pay-Over-Time Partner in the U.S.
Flights available in simple monthly or bi-weekly payments, with no hidden or late fees SAN…